在青少年和年轻成年人体质指数和levonorgestrel器件驱逐
Megan Masten1, Heami Yi2, Laurel Beaty3
1Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Journal of pediatric and adolescent gynecology
|March 10, 2024
概括
具有较高体重指数百分位数 (BMIP) 的青少年和年轻成年人或接受代谢和减肥手术 (MBS) 的青少年和年轻成年人面临levonorgestrel宫内装置 (LNG-IUD) 排泄的风险增加. 这一发现凸显了在为这一群体选择避孕药时考虑体重的重要性.
科学领域:
- 生殖健康 生殖健康
- 青少年医学 青少年医学
- 避孕药是一种避孕药,用于避孕.
背景情况:
- 列沃诺格斯特勒宫内器械 (LNG-IUD) 是有效的长效可逆避孕药.
- 了解影响LNG-IUD驱逐的因素对于有效的计划生育至关重要,特别是在青少年和年轻人 (AYA) 中.
- 以前的研究还没有完全阐明人体质量对AYALNG-IUD保留的影响.
研究的目的:
- 调查体质指数百分位数 (BMIP) 与10-24岁无孕女性LNG-IUD驱逐风险之间的关联.
- 评估是否进行代谢和减肥手术 (MBS) 在这个人口群体中影响LNG-IUD驱逐率.
- 提供基于证据的见解,以优化不同体重的AYA的避孕护理.
主要方法:
- 追溯对588名年龄在10-19岁的无孕女性进行图表审查,这些女性接受了52毫克的LNG-IUD.
- 分析的重点是身体质量指数百分位数 (BMIP),以及在代谢和减肥手术 (MBS) 期间是否发生LNG-IUD放置.
- 统计方法包括描述性统计,奇方位/费舍尔精确测试和后勤回归来评估驱逐风险.
主要成果:
- 在12个月内,5.6%的患者经历了LNG-IUD驱逐.
- 每个单位的BMIP增加都与驱逐几率的3%增加有关 (P = .008).
- 较高的BMIP类别和接受MBS显着与LNG-IUD驱逐的可能性增加有关 (OR = 2.77-4.28和OR = 3.23,分别).
结论:
- 青少年和年轻成年人具有更高的BMIP显著增加LNG-IUD驱逐的风险.
- 接受MBS治疗的患者也表现出更高的LNG-IUD驱逐的可能性.
- 这些发现强调了在选择和管理AYA的避孕方法时,需要考虑体重和外科病史.
相关概念视频
Birth Control Methods
248
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
248
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Dose-Response Relationship: Overview
3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
Insulin: Dosing Regimen and Adverse Effects
170
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
170
Drug Delivery: Parenteral Route
524
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
524
Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K


